Status:
TERMINATED
POWER UP: Participating Online While Exercising to Recover Using Play
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Exercise
Central Nervous System Tumors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We will conduct a two-phase study. The first phase is to adapt and develop an active video game (AVG)-centered lifestyle physical activity (PA) intervention (POWER UP) for adolescents and young adults...
Detailed Description
Objective: To develop (Aim 1) and test (Aim2, Primary Objective) the feasibility and acceptability of a virtually delivered, group-based active video game-centered lifestyle physical activity interve...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- In order to be eligible to participate in Aim 1 of this study, an individual must meet all of the following criteria:
- Round 1 focus groups:
- Oncologists who are caring for AYA cancer survivors or
- Survivorship care providers who actively engage with AYA cancer survivors
- Round 2 focus groups:
- AYA cancer survivors age 15-39 years old
- Self-reported diagnosis of a primary benign or malignant CNS tumor or confirmed diagnosis of primary benign or malignant CNS tumor radiographically or pathologically when available
- ≤1-year post surgery and can have other tumor-directed treatment (e.g., radiation and/or chemotherapy)
- Participants and/or guardians are willing and able to provide informed consent
- Able to speak, read, and understand English
- Daily access to the web
- Can receive physical therapy because this is part of the standard of care
- In order to be eligible to participate in Aim 2 of this study, an individual must meet all of the following criteria:
- Age 15-39 years old
- Self-reported diagnosis of a primary benign or malignant CNS tumor or confirmed diagnosis of primary benign or malignant CNS tumor radiographically or pathologically when available
- ≤1-year post surgery and can have other tumor-directed treatment (e.g., radiation and/or chemotherapy)
- Participant is insufficiently active (reports less than 150 minutes of planned moderate-vigorous intensity activity per week in the prior week)
- Able to speak, read, and understand English
- Daily access to the web
- Approval to participate from the oncology care team
- Participants and/or guardians are willing and able to provide informed consent
- Able to move arms and legs as well as ambulate safely with and without a gait aid
- Available space on the smartphone to download required apps
- Can receive physical therapy because this is part of the standard of care
- Participants and/or guardians are willing and able to provide informed consent for protocol PA18-0130 (Pediatric Energy Balance Data Repository Study), companion protocol for the Fitbit application/assessment.
- Exclusion Criteria
- An individual who meets any of the following criteria will be excluded from participation in Aim 1 of this study:
- Round 1 Focus Groups:
- 1\. Do not have access to the internet
- Round 2 Focus Groups:
- Another member of the household is a participant or staff member on this trial
- Do not have access to the internet
- In foster care or is incarcerated
- Cognitive and/or major sensory deficits that would impede the completion of research activities and assessments as deemed by the clinical team.
- Self-reported diagnosis of a metastatic CNS tumor or confirmed diagnosis of a metastatic CNS tumor radiographically or pathologically when available
- An individual who meets any of the following criteria will be excluded from participation in Aim 2 of this study:
- Currently pregnant
- Currently have dementia
- Plans to travel for more than 2 weeks at a time during the study period where the participant is not able to sign in to join the videoconferencing sessions
- Clinical judgment by the oncology care team concerning safety based on the Physical Activity Readiness Questionnaire for Everyone (2020 PAR-Q+)
- Cognitive and/or major sensory deficits that would impede the completion of research activities and assessments as deemed by the clinical team.
- Self-reported diagnosis of a metastatic CNS tumor or confirmed diagnosis of a metastatic CNS tumor radiographically or pathologically when available
- Currently participating in an organized commercial or research-based exercise program
- Another member of the household is a participant or staff member on this trial
Exclusion
Key Trial Info
Start Date :
May 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2025
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT05308407
Start Date
May 4 2022
End Date
July 29 2025
Last Update
August 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030